Hereditary non-polyposis colorectal carcinoma (HNPCC) - a prospective randomized trial for the comparison of prophylactic or extended surgery versus oncological resection in colon or rectum carcinoma

ISRCTN ISRCTN17448795
DOI https://doi.org/10.1186/ISRCTN17448795
Secondary identifying numbers 70-2993 Oh 1
Submission date
09/06/2004
Registration date
27/09/2004
Last edited
17/12/2007
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Gabriela Möslein
Scientific

Klink für Allgemeine und Viszeralchirurgie
Universitätsklinikum Düsseldorf
Düsseldorf
40225
Germany

Phone +49 (0)211/81-16397
Email moeslein@uni-duesseldorf.de

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific title
Study objectivesNot provided at time of registration
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedHNPCC-associated colorectal carcinoma
InterventionSubtotal colectomy vs. oncologic resection (restorative proctocolectomy vs rectum resection/extirpation)
Intervention typeOther
Primary outcome measureNot provided at time of registration
Secondary outcome measuresNot provided at time of registration
Overall study start date01/01/2002
Completion date31/12/2004

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexNot Specified
Target number of participantsNot provided at time of registration
Key inclusion criteria1. Colorectal carcinoma fulfilling the Amsterdam-criteria for HNPCC or
2. Colorectal carcinoma in patients with known pathogenic mismatch repair gene mutation or
3. Colorectal carcinoma at the age of 50 or less and detection of microsatellite instability in a tumor biopsy and
4. Age between 18 and 65 years
5. Operability for subtotal colectomy/(restorative) proctocolectomy as estimated by the surgeon
6. Exclusion of metastases, local resection of the complete tumor likely to be possible
7. Elective tumorsurgical operation
8. Willingness of the patient to participate in surveillance required by the trial
9. Informed consent
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/01/2002
Date of final enrolment31/12/2004

Locations

Countries of recruitment

  • Germany

Study participating centre

Klink für Allgemeine und Viszeralchirurgie
Düsseldorf
40225
Germany

Sponsor information

Deutsche Krebshilfe e. V. - German Cancer Aid (Germany)
Charity

Thomas-Mann-Strasse 40
Bonn
53004
Germany

Phone +49 (0)228/72990-0
Email deutsche@krebshilfe.de
Website http://www.krebshilfe.de/startseite-dkh.html
ROR logo "ROR" https://ror.org/01wxdd722

Funders

Funder type

Charity

Deutsche Krebshilfe e. V. (70-2993 Oh 1)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan